Mabeza, Ronalyn M.
HRN: 24-15-92 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2024
AMPICILLIN 1GM (VIAL)
01/06/2024
01/12/2024
IV
2 Grams
Q6
PROM 4 Hrs
Checking Final Appropriateness
01/07/2024
CO-AMOXICLAV 625MG (TAB)
01/07/2024
01/13/2024
PO
1tab
BID
Rmle
Checking Final Appropriateness